Project Details
Description
A Phase 3, Open-Label, Randomized Trial To Evaluate The Safety and Efficacy Of MP-376 Inhalation Solution (Aeroquin) Versus Tobramycin Inhalation Solution (TIS) In Stable Cystic Fibrosis Patients
| Status | Finished |
|---|---|
| Effective start/end date | 3/15/11 → 6/1/13 |
Funding
- MPEX PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.